Ginkgo Bioworks Holdings (DNA) Retained Earnings (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has reported Retained Earnings for 7 consecutive years, with $6.7 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Retained Earnings rose 1.5% year-over-year to $6.7 billion; the trailing twelve-month figure through Jun 2026 stood at $6.7 billion (up 1.5% YoY), and the FY2025 full-year result was $6.7 billion, up 1.55% from the prior year.
• Retained Earnings held at $6.7 billion in Q2 2026 per DNA's latest filing, from $6.7 billion in the prior quarter.
• Across five years, Retained Earnings topped out at $6.7 billion in Q2 2026 and bottomed at -$4.2 billion in Q3 2022.
• Historically, Retained Earnings has averaged $5.7 billion across 5 years, with a median of $6.5 billion in 2024.
• The widest YoY moves for Retained Earnings: up 89432.76% in 2022, down 287.69% in 2022.
• Over 5 years, Retained Earnings stood at $6.1 billion in 2022, then increased by 4.07% to $6.4 billion in 2023, then gained by 2.65% to $6.6 billion in 2024, then grew by 1.55% to $6.7 billion in 2025, then advanced by 0.63% to $6.7 billion in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered $6.7 billion, $6.7 billion, and $6.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.